Ali Bassir

University of California, Los Angeles

Papers

1

Total Citations

11

H-Index

1

About

Dr. Ali Bassir is a leading researcher in thoracic oncology, with a primary focus on optimizing treatment strategies for non-small cell lung cancer (NSCLC). His work bridges the gap between traditional surgical approaches and emerging minimally invasive techniques, particularly for patients with complex medical profiles. Dr. Bassir’s most notable contribution is his 2022 systematic review and network meta-analysis protocol, which directly compares surgical resection, radiotherapy, and percutaneous thermal ablation for stage 1 NSCLC. This seminal work, cited 11 times, addresses a critical clinical dilemma: how to treat patients who are poor surgical candidates due to advanced disease or comorbidities. By establishing a rigorous framework for evaluating these modalities, Dr. Bassir is helping to shift the paradigm toward personalized, less invasive care. His research is particularly impactful for the growing population of elderly or frail patients, offering evidence-based guidance on thermal ablation as a viable alternative to surgery. Dr. Bassir’s dedication to improving outcomes through comparative effectiveness research marks him as a rising authority in the field of interventional oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis
11 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of California, Los Angeles

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago